Safety of intra-aortic balloon pump using glycoprotein IIb/IIIa antagonists

Clinical Cardiology

Volumn 32, Issue 2, 2009, Pages 99-103

  Laish Farkash, Avishag ^a,b   Hod, Hanoch ^a,b   Matetzky, Shlomo ^a,b   Guetta, Victor ^a,b  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Complications; Glycoprotein iib iiia antagonists; Intra aortic balloon pump; Myocardial infarction

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; FIBRINOGEN RECEPTOR; HEPARIN;

ADULT; AGED; AORTA BALLOON; ARTICLE; BLEEDING; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG COMBINATION; EQUIPMENT; FEMALE; HEART INFARCTION; HUMAN; MALE; MIDDLE AGED; PROSPECTIVE STUDY; THROMBOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY;

ADULT; AGED; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTICOAGULANTS; DRUG THERAPY, COMBINATION; EQUIPMENT SAFETY; FEMALE; HEMORRHAGE; HEPARIN; HUMANS; INTRA-AORTIC BALLOON PUMPING; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; PROSPECTIVE STUDIES; THROMBOSIS; YOUNG ADULT;

EID: 70349914105     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.20297     Document Type: Article

References (22)

1. Sutorius DJ, Majeski JA, Miller SF: Vascular complications as a result of intra-aortic balloon pumping. Am Surg 1979;45:512-516 (Pubitemid 10166221)
2. Trost JC, Hillis LD: Intra-aortic balloon counterpulsation. Am J Cardiol 2006;07:1391-1398
3. Jiang CY, Zhao LL, Wang JA, Mohammod B: Anticoagulation therapy in intra-aortic balloon counterpulsation: Does IABP really need anti-coagulation? J Zhejiang Univ Sci 2003;4:607-611
4. Kuki S, Taniguchi K, Masai T, Yoshida K, Yamamoto K, et al.: Usefulness of the low profile "True 8" intra-aortic balloon pumping preventing limb ischemia. ASAIO J 2001;47(6):611-614 (Pubitemid 33064151)
5. Ferguson JJ, Cohen M, Freedman RJ, Stone GW, Miller MF, et al.: The current practice of intra-aortic balloon counterpulsation: Results from the Benchmark Registry. J Am Coll Cardiol 2001;38:1456-1462 (Pubitemid 33033026)
6. Cohen M, Urban P, Christenson JT, Joseph DL, Freedman RJ Jr, et al.: Benchmark Registry Collaborators: Intra-aortic balloon counterpulsation in US and non-US centers: results of the Becnchmark Registry. Eur Heart J 2003;24:1763-1770 (Pubitemid 37236866)
7. Meco M, Gramegna G, Yassini A, Bellisario A, Mazzaro E, et al.: Mortality and morbidity from intra-aortic balloon pumps. Risk analysis. J Cardiovasc Surg 2002;43:17-23 (Pubitemid 34262644)
8. Cohen M, Dawson MS, Kopistansky C, McBride R: Sex and other predictors of Intra-aortic balloon pump complication: prospective study of 1119 consecutive patients. Am Heart J 2000;139:282-287 (Pubitemid 30090805)
9. Aguirre FV, Topol EJ, Ferguson JJ, Anderson K, Blankenship JC, et al.; The EPIC Investigators: Bleeding complications with the chimeric antibody to platelet glycoprotein IIb/IIIa integrelin in patients undergoing percutaneous coronary intervention. EPIC investigators. Circulation 1995;91:2882-2890
10. Dogrell SA: Clinical trials with glycoprotein IIb/IIIa antagonists-no benefit without bleeding? Drugs Today (Barc) 2001;37:509-531
11. Brener SJ, Barr LA, Burchenal JE, Katz S, George BS, et al.: Randomized, placebo-controlled trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarction. ReoPro and Primary PTCA Organization and Randomized Trial (RAPPORT) Investigators. Circulation 1998;98:734-741 (Pubitemid 28391837)
12. Galeote G, Hussein M, Sobrino N, Calvo L, Sanchez-Recalde A, et al.:Use of a combination of enoxaparin or unfractionated heparin and abciximab during percutaneous coronary interventions: a randomized pilot study. Rev Esp Cardiol 2002;55:1261-1266 (Spanish) (Pubitemid 36157472)
13. Kinnaird TD, Stabile E, Mintz GS, Lee CW, Canos DA, et al.: Incidence, predictors, and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventions. Am J Cardiol 2003;92:930-935 (Pubitemid 37214804)
14. Lacy CF, Armstrong LL, Goldman MP, Lance MP: Drug Information Handbook International (12th edition). Ohio: Lexi-Comp Inc, 2004-5
15. Bovill EG, Terrin ML, Stump DC, Berke AD, Frederick M, et al.: Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI), Phase II Trial. Ann Intern Med 1991;115:256-265
16. Stone GW, Ohman EM, Miller MF, Joseph DL, Christenson JT, et al.: Contemporary utilization and outcomes of intra-aortic balloon counterpulsation in acute myocardial infarction: the Benchmark Registry. J Am Coll Cardiol 2003;41:1940-1945 (Pubitemid 36677111)
17. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, et al.: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on practice Guidelines. J Am Coll Cardiol 2004;44:671-719
18. Mahaffey KW, Granger CB, Sloan MA, Thompson TD, Gore JM, et al.; GUSTO-1 Investigators: Risk factors for in-hospital nonhemorrhagic stroke in patients with acutemyocardial infarction treated with thrombolysis. Circulation 1998;97:757-764 (Pubitemid 28135338)
19. Angeja BG, Rundle AC, Gurwitz JH, Gore JM, Barron HV: Death or nonfatal stroke in patients with acute myocardial infarction treated with tissue plasminogen activator: participants in the National Registry of Myocardial Infarction 2. Am J Cardiol 2001;87:627-630 (Pubitemid 32178461)
20. Spencer FA, Gore JM, Yarzebski J, Lessard D, Jackson EA, et al.: Trends (1986 to 1999) in the incidence and outcomes of in-hospital stroke complicating acute myocardial infarction (the Worcester heart attack study). Am J Cardiol 2003;92:383-388 (Pubitemid 36959872)
21. Budaj A, Flasinska K, Gore JM, Anderson FA Jr, Dabbous OH, et al.; GRACE Investigators: Magnitude of and risk factors for in-hospital and postdischarge stroke in patients with acute coronary syndromes. Findings from a global registry of acute coronary events. Circulation 2005;111:3242-3247 (Pubitemid 40874996)
22. Azeem T, Stephens-Lloyd A, Spyt T, Hartshorne R, Gershlick AH: Intra-aortic balloon counterpulsation: variations in use and complications. Int J Cardiol 2004;94:255-259 (Pubitemid 38490670)